JESSICA SPITELLI: Open Payments
NPI 1740757012 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 14 payments from 8 companies in 2025. Trend: 2023 $165 · 2024 $248 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $104 |
| QOL Medical, LLC | 3 | $80 |
| Janssen Biotech, Inc. | 2 | $63 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Ardelyx, Inc. | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
Products named: Sucraid, ENTYVIO, TREMFYA, REZDIFFRA, IBSRELA, EOHILIA, IQIRVO, OMVOH.
Industry payments across IL — which companies pay providers there.
